These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 29547547)

  • 1. Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection.
    Murray MJ; Peters NE; Reeves MB
    Pathogens; 2018 Mar; 7(1):. PubMed ID: 29547547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro.
    Noriega VM; Haye KK; Kraus TA; Kowalsky SR; Ge Y; Moran TM; Tortorella D
    J Virol; 2014 Aug; 88(16):9391-405. PubMed ID: 24920803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Latency-Associated Expression of Human Cytomegalovirus US28 Attenuates Cell Signaling Pathways To Maintain Latent Infection.
    Krishna BA; Poole EL; Jackson SE; Smit MJ; Wills MR; Sinclair JH
    mBio; 2017 Dec; 8(6):. PubMed ID: 29208743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells.
    Saffert RT; Penkert RR; Kalejta RF
    J Virol; 2010 Jun; 84(11):5594-604. PubMed ID: 20335255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of human cytomegalovirus microRNA expression during lytic and quiescent infection.
    Shen ZZ; Pan X; Miao LF; Ye HQ; Chavanas S; Davrinche C; McVoy M; Luo MH
    PLoS One; 2014; 9(2):e88531. PubMed ID: 24533100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U
    Goodwin CM; Schafer X; Munger J
    J Virol; 2019 Dec; 93(23):. PubMed ID: 31534044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Cytomegalovirus Enters the Primary CD34
    Lee JH; Kalejta RF
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31118259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.
    Hancock MH; Nelson JA
    Virology (Hyderabad); 2017 Aug; 1(1):. PubMed ID: 29082387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human Nasal Turbinate Tissues in Organ Culture as a Model for Human Cytomegalovirus Infection at the Mucosal Entry Site.
    Alfi O; From I; Yakirevitch A; Drendel M; Wolf M; Meir K; Zakay-Rones Z; Nevo Y; Elgavish S; Ilan O; Weisblum Y; Tayeb S; Gross M; Jonas W; Ives J; Oberbaum M; Panet A; Wolf DG
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32727881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatin-mediated regulation of cytomegalovirus gene expression.
    Reeves MB
    Virus Res; 2011 May; 157(2):134-43. PubMed ID: 20875471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytomegalovirus gene expression is silenced by Daxx-mediated intrinsic immune defense in model latent infections established in vitro.
    Saffert RT; Kalejta RF
    J Virol; 2007 Sep; 81(17):9109-20. PubMed ID: 17596307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies?
    Wills MR; Poole E; Lau B; Krishna B; Sinclair JH
    Cell Mol Immunol; 2015 Mar; 12(2):128-38. PubMed ID: 25132454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective 4-Thiouracil Labeling of RNA Transcripts within Latently Infected Cells after Infection with Human Cytomegalovirus Expressing Functional Uracil Phosphoribosyltransferase.
    Roche KL; Nukui M; Krishna BA; O'Connor CM; Murphy EA
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30089702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diverse immune evasion strategies by human cytomegalovirus.
    Noriega V; Redmann V; Gardner T; Tortorella D
    Immunol Res; 2012 Dec; 54(1-3):140-51. PubMed ID: 22454101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Recombinant Human Cytomegaloviruses Encoding IE1 Mutants L174P and 1-382 Reveals that Viral Targeting of PML Bodies Perturbs both Intrinsic and Innate Immune Responses.
    Scherer M; Otto V; Stump JD; Klingl S; Müller R; Reuter N; Muller YA; Sticht H; Stamminger T
    J Virol; 2016 Feb; 90(3):1190-205. PubMed ID: 26559840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Cytomegalovirus US28 Is Important for Latent Infection of Hematopoietic Progenitor Cells.
    Humby MS; O'Connor CM
    J Virol; 2015 Dec; 90(6):2959-70. PubMed ID: 26719258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host microRNA regulation of human cytomegalovirus immediate early protein translation promotes viral latency.
    O'Connor CM; Vanicek J; Murphy EA
    J Virol; 2014 May; 88(10):5524-32. PubMed ID: 24599990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cytomegalovirus latent infection alters the expression of cellular and viral microRNA.
    Fu M; Gao Y; Zhou Q; Zhang Q; Peng Y; Tian K; Wang J; Zheng X
    Gene; 2014 Feb; 536(2):272-8. PubMed ID: 24361963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innate nuclear sensor IFI16 translocates into the cytoplasm during the early stage of in vitro human cytomegalovirus infection and is entrapped in the egressing virions during the late stage.
    Dell'Oste V; Gatti D; Gugliesi F; De Andrea M; Bawadekar M; Lo Cigno I; Biolatti M; Vallino M; Marschall M; Gariglio M; Landolfo S
    J Virol; 2014 Jun; 88(12):6970-82. PubMed ID: 24696486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMV immune evasion and manipulation of the immune system with aging.
    Jackson SE; Redeker A; Arens R; van Baarle D; van den Berg SPH; Benedict CA; Čičin-Šain L; Hill AB; Wills MR
    Geroscience; 2017 Jun; 39(3):273-291. PubMed ID: 28647908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.